Ansell doubles down on PPE sales
Ansell's latest acquisition combines growth prospects, better margins, and an attractive price.
Ansell: Interim result 2024
A weak result for Healthcare sales was partially offset by Industrial strength.
No forced labour at Ansell's annual meeting
A focus on slavery and innovation made this general meeting more interesting than usual.
Ansell: unbelievable reasons
Ansell didn't see the slowdown coming. Or did it, and management just didn't act?
Ansell: Interim result 2023
Healthcare sales were down but price increases helped to support margins.
Ansell's share price rises
With the share price up since the full-year result, it's time to take a breather.
Ansell: Interim result 2022
As margins shrink, is there still hope for profits to remain high after the pandemic?
Ansell lowers guidance
A surprise profit downgrade has caused the stock to tumble, but Ansell is still a pandemic winner.
Ansell: the bear case is overrated
This glove maker has a bumpy year ahead, but investors are being well compensated for the risks.
Ansell: Result 2021
Medical gloves were in hot demand but rising material costs are a risk to margins.
Ansell lifts guidance
Ansell continues to benefit from PPE demand and has increased its profit forecasts.
Ansell: Interim result 2021
Healthcare glove sales stole the show, but there were surprises in the Industrial division too.
Ansell: Result 2020
Single-use gloves have been flying off the shelves and industrial gloves have been surprisingly popular too.
Ansell's price guide raised
We aren't ready to let go of the world's largest maker of personal protective equipment.
Ansell price guide lowered
Ansell's share price has fallen, but with industrial sales likely to slow, we're increasing our margin of safety.
Ansell: Interim result 2020
Coronavirus and weakening competitors are a boon for the Healthcare division, but Industrial sales continue to lag.
Ansell: Result 2019
Though each division had its pain points, we're optimistic about Ansell's future.
Ansell and the Trump tariffs
A US-China trade war sounds bad, but it might be a blessing for this glove maker.
Ansell: Interim result 2019
Pain in emerging markets and rising raw material prices have led to a poor six months for this glove maker.
Ansell: Result 2018
Ansell has reported moderate organic growth, but rising material costs took a bite out of profits.
Ansell: Selling shovels in a gold rush
If you want exposure to emerging markets, look no further than this glove maker.
Ansell: Interim result 2018
A strong year of sales was offset by rising raw material prices, but there was other good news.
Call 1300 880 160
Start a chat
Schedule a call
